Cornelia Kruse-Müller

Title: Cornelia Kruse-Müller: Innovator in Immunological Determination

Introduction

Cornelia Kruse-Müller is a notable inventor based in Edewecht, Germany. She has made significant contributions to the field of immunology, particularly in the determination of specific antibodies. Her innovative approach has led to the development of a patented method that enhances the accuracy of immunological testing.

Latest Patents

Cornelia holds a patent for the invention titled "Determination of a specific immunoglobulin using multiple antigens." This invention concerns a method for the immunological determination of a specific antibody in a sample liquid. The method involves incubating the sample liquid in the presence of a solid phase with two antigens directed against the antibody to be determined. One antigen carries at least one marker group, while the second antigen is either bound to the solid phase or is in a form capable of binding to it. The antibody is detected by determining the marker group in the solid phase or in the liquid phase. Notably, at least one of the two antigens contains several epitope regions that react with the antibody to be determined. Cornelia has 1 patent to her name.

Career Highlights

Cornelia Kruse-Müller is associated with Roche Diagnostics GmbH, a leading company in the field of diagnostics. Her work at Roche has allowed her to contribute to advancements in medical technology and improve diagnostic methods.

Collaborations

Some of her notable coworkers include Ursula-Henrike Wienhues and Eva Höss. Their collaboration has likely fostered an environment of innovation and shared expertise in their respective fields.

Conclusion

Cornelia Kruse-Müller is a pioneering inventor whose work in immunological determination has made a significant impact in the field of diagnostics. Her patented method showcases her dedication to advancing medical technology and improving patient outcomes.